about
PDE4 as a target for cognition enhancementNeuroprotective effect of novel cognitive enhancer noopept on AD-related cellular model involves the attenuation of apoptosis and tau hyperphosphorylationAlzheimer's disease and age-related memory decline (preclinical)Identification and development of specific inhibitors for insulin-regulated aminopeptidase as a new class of cognitive enhancers.Phenserine efficacy in Alzheimer's disease.Can small molecules provide truly effective enhancement of cognition? Current achievements and future directions.Epigenetic Treatment of Neurodegenerative Disorders: Alzheimer and Parkinson Diseases.
P2860
Q27008296-374EAD86-7979-4E5B-8FA6-BCA24605DEB4Q27499804-8F85202F-C227-4F40-92B9-40F7ABC3CFDEQ35041190-925E1186-DB17-4E7C-9E1C-42CA79B32B29Q35210016-2CAB6F9A-175E-4FB1-AA3E-F46B42083E72Q37510264-C08C9BC9-B06C-4363-A461-CD97FE265DC4Q37867702-73E68C53-C99B-4B6F-A810-B9D03E16B8B0Q38742951-977B0C43-1FC5-4D97-9AD1-98E74FA39367
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Emerging cognitive enhancing drugs.
@en
Emerging cognitive enhancing drugs.
@nl
type
label
Emerging cognitive enhancing drugs.
@en
Emerging cognitive enhancing drugs.
@nl
prefLabel
Emerging cognitive enhancing drugs.
@en
Emerging cognitive enhancing drugs.
@nl
P2860
P1476
Emerging cognitive enhancing drugs.
@en
P2093
Jerry J Buccafusco
P2860
P304
P356
10.1517/14728210903257796
P407
P577
2009-12-01T00:00:00Z